Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
110.22
+1.82 (1.68%)
Nov 22, 2024, 4:00 PM EST - Market closed

Company Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.

The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

It also offers robotic, surgical, and bone cement products. The company’s products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.

It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups.

The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015.

Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings logo
Country United States
Founded 1927
Industry Medical Devices
Sector Healthcare
Employees 18,000
CEO Ivan Tornos

Contact Details

Address:
345 East Main Street
Warsaw, Indiana 46580
United States
Phone 574 373 3333
Website zimmerbiomet.com

Stock Details

Ticker Symbol ZBH
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001136869
CUSIP Number 98956P102
ISIN Number US98956P1021
Employer ID 13-4151777
SIC Code 3842

Key Executives

Name Position
Ivan Tornos Chief Operating Officer, President, Chief Executive Officer and Director
Suketu P. Upadhyay Chief Financial Officer and Executive Vice President of Finance, Operations and Supply Chain
Sang Yi President of Asia Pacific
Wilfred van Zuilen Group President of Europe, Middle East and Africa
Paul A. Stellato Vice President, Controller and Chief Accounting Officer
Shaun Braun Senior Vice President and Chief Information and Technology Officer
Rachel H. Ellingson Senior Vice President and Chief Administrative Officer
David M. DeMartino Senior Vice President of Investor Relations
Angela Main Senior Vice President, Global Chief Compliance Officer and Associate General Counsel of Asia Pacific
Lori Winkler Senior Vice President and Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Nov 22, 2024 CERT Certification by an exchange approving securities for listing
Nov 20, 2024 8-A12B Registration of securities
Nov 20, 2024 8-K Current Report
Nov 19, 2024 8-K Current Report
Nov 14, 2024 424B5 Filing
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 FWP Free Writing Prospectus
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 424B5 Filing
Oct 30, 2024 10-Q Quarterly Report